MGC018 With or Without MGA012 in Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ashley Ward, M.D.
MacroGenics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St Vincent'S Health Network (kinghorn Cancer Centre)
Darlinghurst, Australia
- Austin Health - Olivia Newton John Cancer Center
Heidelberg, Australia
- Calvary Mater Newcastle
Waratah, Australia
- the University of Queensland - Princess Alexandra Hospital (pah)
Woolloongabba, Australia
- Samodzielny Publiczny Zakład Opieki Zdrowotnej Szpital Uniwersytecki W Krakowie Oddział Kliniczny Onkologii
Krakow, Poland
- Med-Polonia Sp. Z O.O.
Poznan, Poland
- Magodent Sp. Z O.O. Szpital Elbląska Oddział Onkologii Klinicznej/ Chemioterapii
Warsaw, Poland
- Narodowy Instytut Onkologii Im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy Oddział Badań Wczesnych Faz
Warsaw, Poland
- Hospital Universitario Vall D'Hebron
Barcelona, Spain
- Institut Català D'Oncologia - Hospital Universitari Germans Trias I Pujol
Barcelona, Spain
- Hospital Ruber Internacional
Madrid, Spain
- Hospital Universitario Hm Sanchinarro
Madrid, Spain
- Ucla Department of Medicine - Hematology/oncology
Santa Monica, California, United States
- Sibley Memorial Hospital
Washington D.C., District of Columbia, United States
- the Johns Hopkins Kimmel Cancer Center
Baltimore, Maryland, United States
- Start Midwest
Grand Rapids, Michigan, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
- Carolina Biooncology Institute
Huntersville, North Carolina, United States
- Inova Schar Cancer Institute
Fairfax, Virginia, United States
- Virginia Cancer Specialist
Fairfax, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Nov 2018
- Primary completion
- 18 Mar 2023
- Completion
- 18 Mar 2023
- Last update posted
- 31 Jul 2025
- Registered enrollment
- 143
- Registry id
- NCT03729596
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.